Kathryn DeSear

CLIN ASO PROF

PH PHARMACY EDUCATION AND PRAC

sort by:

GRANT
Ceftazidime-Avibactam versus Meropenem-Vaborbactam for the treatment of bloodstream infections and/or pneumonia due to carbapenem-resistant EnterobacteraLes
Melinta Therapeutics16 Jul 2025 - 30 Nov 2026
Active
GRANT
Optimizing escalation: Ceftolozane/tazobactam versus treatment with traditional anti-pseudomonal ß-lactams for pneumonia or bloodstream infections due to MDR P. aeruginosa (STEWARDS)
Merck Sharp & Dohme4 Sep 2024 - 12 Dec 2027
Active
GRANT
Cefiderocol treatment Versus ceftolozane/tazobactam for the treatment of pneumonia and/or bloodstream Infections due to multidrug-resistant Pseudomonas aeruginosa (CONVINCE)
Shionogi Inc2 Apr 2024 - 1 Apr 2027
Active
GRANT
Prevalence of Cefazolin Inoculum Effect in Mcthicillin Susceptible Staphylococcus aureus Bacteremia
UF Health Shands Hospital16 Apr 2021 - 1 Jul 2024
Expired

GRANTS